Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

5.9K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.9K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

566
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
566
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

355
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
355
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

369
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
369
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

317
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
317
Methods of Medium Optimization01:28

Methods of Medium Optimization

63
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
63

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Asymmetric Chichibabin diradicaloids: synthesis <i>via</i> oxidation of SOMO-HOMO inversion radicals and near-infrared absorption for electrochromism.

Chemical science·2026
Same author

Metabolomic differences in the Ophiura sarsii complex from the Yellow Sea Cold Water Mass and Bering Sea Cold Pool.

Comparative biochemistry and physiology. Part D, Genomics & proteomics·2026
Same author

Establishment and characterization of an ovarian cell line from red seabream (Pagrus major) and its application in fish toxicology.

In vitro cellular & developmental biology. Animal·2026
Same author

SETD7 depletion enhances white adipose browning and ameliorates metabolic disorders in obese mice.

Cell death and differentiation·2026
Same author

Diagnostic performance of contrast-enhanced ultrasound in distinguishing lymphoma from non-lymphoma lesions in salivary gland: a retrospective study.

Frontiers in oncology·2026
Same author

PRKN Ser131 phosphorylation promotes cigarette smoke-induced mitophagy impairment and epithelial cell senescence via MKK3/p38 MAPK activation: An in vitro and in vivo study.

Tobacco induced diseases·2026

相关实验视频

Updated: Apr 13, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.6K

使用定量高含量分析和高通量查进行衰老调节药物开发的有效系统

Yajie Hu1, Xueqi Xue1, Tian Han1

  • 1Discovery Biology Unit, WuXi Biology, WuXi AppTec Ltd., Shanghai, China.

Communications biology
|August 30, 2025
PubMed
概括

这项研究引入了一种新的高含量分析系统,用于评估细胞衰老标志物,改善药物开发的老化研究. 该系统能够对形,解和诱导剂进行高通量选.

更多相关视频

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K
SA-&#946;-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.2K

相关实验视频

Last Updated: Apr 13, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.6K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K
SA-&#946;-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.2K

科学领域:

  • 生物生态学
  • 药物发现
  • 细胞生物学

背景情况:

  • 细胞衰老对于衰老研究和抗衰老药物开发至关重要.
  • 目前与衰老相关的β-galactosidase (SA-β-gal) 试验是非定量和劳动密集的.
  • 需要高效,高吞吐量的方法来评估衰老调节器.

研究的目的:

  • 开发和验证多重高含量分析系统,用于对老化调节器进行高通量选.
  • 为了能够对老化,老化和老化诱导剂进行定量评估.
  • 促进抗衰老疗法的药物开发.

主要方法:

  • 开发一个多重高含量分析系统.
  • 在纤维细胞上对衰老调节器进行高通量选.
  • 对老化调节器的IC50或EC50值的确定.

主要成果:

  • 开发的系统对于评估衰老调节器是有效和可重复的.
  • 该系统允许同时评估老化,老化和老化诱导剂.
  • 确定了调节MMC诱导衰老的新分子实体,这表明了新的细胞点.

结论:

  • 这种新型高含量分析系统显著提升了老化调节器的选和评估.
  • 这一平台对于加速药物研发和抗衰老治疗至关重要.
  • 发现新的分子实体凸显了该系统发现新疗法目标的潜力.